Big drop in pay-for-delay questions, Reeves says
Latham & Watkins antitrust chair Amanda Reeves has said that drugmakers are seeking counselling regarding pay-for-delay significantly less often than they did in the past.
Subscribe to Global Competition Review
Subscribe and start reading now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10